Announcements Trials
Browse Landscape

Status

Completed 187Terminated 67Unknown 57Recruiting 39Active not recruiting 32Withdrawn 21Not yet recruiting 9Suspended 3Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

fludarabine 1Rituximab 1R-CHOP protocol 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leukapheresis 1Lenalidomide 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Lymphoma, Large B-Cell, Diffuse × Rituximab × Clear all
NCT05690191 2023-01-19

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Second Affiliated Hospital of Soochow University

Enrolling by invitation
169 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡